S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
NASDAQ:CRGX

CARGO Therapeutics (CRGX) Stock Price, News & Analysis

$20.84
-0.74 (-3.43%)
(As of 04/12/2024 ET)
Today's Range
$20.30
$22.21
50-Day Range
$20.74
$32.23
52-Week Range
$13.14
$33.92
Volume
439,601 shs
Average Volume
430,173 shs
Market Capitalization
$820.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$29.67

CARGO Therapeutics MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
42.4% Upside
$29.67 Price Target
Short Interest
Bearish
13.63% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.56mentions of CARGO Therapeutics in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($5.60) to ($5.65) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.85 out of 5 stars

Medical Sector

846th out of 926 stocks

Biological Products, Except Diagnostic Industry

140th out of 152 stocks

CRGX stock logo

About CARGO Therapeutics Stock (NASDAQ:CRGX)

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients in the Unites States. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate, which is in phase 2 trails, designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.

CRGX Stock Price History

CRGX Stock News Headlines

CARGO Therapeutics (NASDAQ:CRGX) Sees Large Volume Increase
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Spyre Therapeutics, Inc. (SYRE)
3 New Stock Listings That Can Deliver Multibagger Returns
CRGX CARGO Therapeutics, Inc.
CARGO Therapeutics Inc.
Cargo Therapeutics Inc CRGX
CARGO Therapeutics Announces Scientific Advisory Board
CARGO Therapeutics Inc (CRGX)
See More Headlines
Receive CRGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CARGO Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/21/2024
Today
4/13/2024
Next Earnings (Estimated)
6/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:CRGX
Previous Symbol
NASDAQ:CRGX
Fax
N/A
Employees
116
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$29.67
High Stock Price Target
$34.00
Low Stock Price Target
$23.00
Potential Upside/Downside
+42.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$820.26 million
Optionable
N/A
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Ms. Gina Chapman (Age 56)
    President, CEO & Director
    Comp: $755.35k
  • Dr. Crystal L. Mackall M.D. (Age 63)
    Co-Founder
    Comp: $160k
  • Dr. Shishir Gadam Ph.D. (Age 57)
    Chief Technical Officer
    Comp: $674.03k
  • Dr. Robbie Majzner M.D.
    Founder & Chair of Scientific Advisory Board
  • Ms. Nancy Goodman J.D.
    Founder
  • Dr. Louai Labanieh
    Founder
  • Mr. Anup Radhakrishnan (Age 44)
    CFO, Secretary & Chief Business Officer
  • Dr. Corinne D. Epperly M.D. (Age 46)
    M.P.H., Chief Operating Officer
  • Mr. Faisal Shawwa M.B.A.
    Senior Vice President of Finance & Accounting
  • Dr. Michael Ports Ph.D. (Age 43)
    Chief Scientific Officer

CRGX Stock Analysis - Frequently Asked Questions

Should I buy or sell CARGO Therapeutics stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CARGO Therapeutics in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CRGX shares.
View CRGX analyst ratings
or view top-rated stocks.

What is CARGO Therapeutics' stock price target for 2024?

4 brokers have issued 1 year price objectives for CARGO Therapeutics' shares. Their CRGX share price targets range from $23.00 to $34.00. On average, they predict the company's stock price to reach $29.67 in the next twelve months. This suggests a possible upside of 42.4% from the stock's current price.
View analysts price targets for CRGX
or view top-rated stocks among Wall Street analysts.

How have CRGX shares performed in 2024?

CARGO Therapeutics' stock was trading at $23.15 at the beginning of the year. Since then, CRGX shares have decreased by 10.0% and is now trading at $20.84.
View the best growth stocks for 2024 here
.

Are investors shorting CARGO Therapeutics?

CARGO Therapeutics saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 3,590,000 shares, an increase of 63.2% from the March 15th total of 2,200,000 shares. Based on an average daily volume of 291,700 shares, the days-to-cover ratio is currently 12.3 days. Approximately 13.6% of the company's stock are short sold.
View CARGO Therapeutics' Short Interest
.

When is CARGO Therapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 20th 2024.
View our CRGX earnings forecast
.

How were CARGO Therapeutics' earnings last quarter?

CARGO Therapeutics, Inc. (NASDAQ:CRGX) announced its quarterly earnings results on Thursday, March, 21st. The company reported ($1.49) earnings per share for the quarter, topping the consensus estimate of ($1.62) by $0.13.

When did CARGO Therapeutics IPO?

CARGO Therapeutics (CRGX) raised $281 million in an initial public offering on Friday, November 10th 2023. The company issued 18,750,000 shares at $15.00 per share.

When does CARGO Therapeutics' lock-up period expire?

CARGO Therapeutics' lock-up period expires on Wednesday, May 8th. CARGO Therapeutics had issued 18,750,000 shares in its IPO on November 10th. The total size of the offering was $281,250,000 based on an initial share price of $15.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the end of the lock-up period.

How do I buy shares of CARGO Therapeutics?

Shares of CRGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CRGX) was last updated on 4/14/2024 by MarketBeat.com Staff

From Our Partners